ERBB2 and breast cancer: The introduction of DNA microarray technology defined initially four intrinsic subtypes of breast cancer, which were later extended to five by Perou et al.: Luminal A, Luminal B, HER2-enriched, Basal-like and Claudin-low or Mesenchymal-like [5-7].